HBSAG LEVELS DURING ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B: PEGINTERFERON VERSUS ENTECAVIR

被引：1
|
作者：
Reijnders, J. G. P. [1 ]
Rijckborst, V. [1 ]
Sonneveld, M. J. [1 ]
Scherbeijn, S. M. J. [1 ]
Boucher, C. A. B. [1 ]
Hansen, B. E. [1 ]
Janssen, H. L. A. [1 ]
机构：
[1] Erasmus MC Univ Med Ctr, Rotterdam, Netherlands
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 52卷
关键词：
D O I：
10.1016/S0168-8278(10)61022-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S395 / S395
页数：1
相关论文
共 50 条
  • [31] Switching to peginterferon for chronic hepatitis B patients with hepatitis B e antigen seroconversion on entecavir - A prospective study
    Chan, Henry L. Y.
    Chan, Fiona W. S.
    Hui, Aric J.
    Li, Michael K. K.
    Chan, Kam H.
    Wong, Grace L. H.
    Loo, Ching K.
    Chim, Angel M. L.
    Tse, Chi H.
    Wong, Vincent W. S.
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (01) : 126 - 135
  • [32] Measurement of HBsAg Concentration During Antiviral Therapy of Hepatitis B: Who, When, and Why
    Perrillo, Robert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (10): : 1774 - 1776
  • [33] Hepatitis B Switch of Entecavir to Peginterferon α-2a
    Hofmann-Assmus, Marion
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2015, 53 (02): : 78 - 78
  • [34] ASSOCIATION BETWEEN GENOTYPE AND BASELINE HBsAg LEVELS AND THE HBsAg LEVELS AT HBeAg SEROCLEARANCE IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH ENTECAVIR
    Peng, C. -Y.
    Lai, H. -C.
    Su, W. -P.
    Lin, C. -H.
    Chuang, P. -H.
    Chen, S. -H.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S430 - S430
  • [35] Comparison of the Effect of Entecavir and Tenofovir on Serum HBsAg Levels in Chronic HBe-Negative Hepatitis B Patients
    Plesniak, Robert
    Karpinska, Ewa
    Duczkowska, Marta
    Wawrzynowicz-Syczewska, Marta
    HEPATITIS MONTHLY, 2021, 21 (12)
  • [36] PREDICTION OF HBsAg KINETICS AND HBEAG LOSS DURING ANTIVIRAL THERAPY IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B
    Kim, Hwi Young
    Jang, Tae Soo
    Lee, Joo Ho
    Lee, Hye Ah
    Kwon, Hee-Dae
    HEPATOLOGY, 2020, 72 : 518A - 518A
  • [37] Concerns and Safety of Add-on Versus Switch Peginterferon Therapy for Chronic Hepatitis B
    Vyas, Ashish Kumar
    Jindal, Ankur
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (05) : 1190 - 1191
  • [38] CHANGES IN HEPATIC HBcAg AND HBsAg EXPRESSION DURING ANTIVIRAL THERAPY AND THEIR ROLE IN OUTCOME AMONG PATIENTS WITH CHRONIC HEPATITIS B
    Kattapuram, Meera
    Auh, Sungyoung
    Kleiner, David
    Ghany, Marc G.
    HEPATOLOGY, 2019, 70 : 416A - 416A
  • [39] COMPARISON OF PEGINTERFERON ALFA-2A VERSUS ENTECAVIR IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B WITH MILDLY ELEVATED ALANINE AMINOTRANSFERASE LEVELS
    Chen, X. -F.
    Chen, X. -P.
    Huang, J.
    Chen, W. -L.
    Chen, R.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S328 - S329
  • [40] Reduction of serum leptin levels during antiviral treatment with peginterferon and ribavirin in patients with chronic hepatitis C
    Putz-Bankuti, Csilla
    Stojakovic, Tatjana
    Scharnagl, Hubert
    Bauer, Bernd
    Pock, Hannelore
    Trauner, Michael
    Stauber, Rudolf
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (17-18) : A10 - A10
12345